Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder

Explore clinical trials studying Depressive Disorder. Study availability and eligibility vary by location and protocol.

2,792 public trials 428 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder trial results

Completed

Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT04985942

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Clinical Site Phoenix, Arizona, United States
  • Clinical Site Glendale, California, United States
  • Clinical Site Oceanside, California, United States
  • Clinical Site Redlands, California, United States
View all 54 locations
View Trial Details
Completed

54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

NCT03039192

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • UAB Department of Psychiatry and Behavioral Neurobiology Birmingham, Alabama, United States
  • Metropolitan Neuro Behavioral Institute Chandler, Arizona, United States
  • Collaborative NeuroScience Network Garden Grove, California, United States
  • Yale University New Haven, Connecticut, United States
View all 56 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

NCT02417064

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +2 more
Locations
  • Birmingham, Alabama, United States
  • Little Rock, Arkansas, United States
  • Garden Grove, California, United States
  • Orange, California, United States
View all 90 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

NCT02418585

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +2 more
Locations
  • Birmingham, Alabama, United States
  • Orange, California, United States
  • San Rafael, California, United States
  • Maitland, Florida, United States
View all 48 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

NCT03185819

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Institute of Living/ Hartford Hospital Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • Atlanta Behavioral Research, LLC Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 51 locations
View Trial Details

Related conditions